The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Roche posted higher first-quarter sales that beat analysts’ expectations on higher demand for its key drugs. The Swiss ...

Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...

Roche will invest $50 billion in American manufacturing over the next five years, including building a new facility somewhere in Indiana.The Swiss biotech company said the investment will ...

Roche posted higher first-quarter sales that beat analysts’ expectations on higher demand for its key drugs. The Swiss pharmaceutical giant said Thursday that sales rose to 15.44 billion Swiss ...